3 ms·
Key quote: > The question ultimately comes down to risk vs benefit. We need to get over our evolved but suboptimal instinct to avoid directly causing harm pref
by feross 6y ago
Key quote:
> The question ultimately comes down to risk vs benefit. We need to get over our evolved but suboptimal instinct to avoid directly causing harm preferentially over passively allowing harm to occur. In the end, the amount of harm is all that matters. In a situation like this, delivering a vaccine as quickly as possible while maintaining sufficient safety and efficacy, there is a sweet spot somewhere that minimizes disease, death, and disruption. We want that sweet spot, even it if means delivering a vaccine that has not been tested as much as we would like. It would mean accepting more risk form the vaccine in order to reduce risk from the pandemic.
- Rochus 6y agoLooking at various safety standards, risk/benefit analysis is well established in the medical environment (and only there); e.g. ISO 14971 states "If the residual risk is not judged acceptable using the criteria established in the risk management plan and further risk control is not practicable, the manufacturer may gather and review data and literature to determine if the medical benefits of the intended use outweigh the residual risk."
- infoseek12 6y agoI think that is the key quote but I believe their conclusion about balancing risks is mistaken. People don’t statistically assess risks the way actuaries do, even the most rational people don’t think like that. There’s already a significant percent of the population that believe any number of irrational things about vaccinations. Around a third of Americans aren’t planning to get the vaccine. If there are a significant number of adverse reactions convincing people to behave rationally will become even more difficult. When assessing the risk we can’t just look at the direct effects we also need to consider the effects on how the population at large will behave.